As Executive Vice President, Chief Business and Strategy Officer, Dr. Nicholas Donoghoe leads Business Development, Corporate Strategy and Business Technology Operations at AbbVie, and under his leadership AbbVie has completed more than $20 billion in external innovation deals since 2023. He joined AbbVie in 2019 in a newly created innovation role supporting cross-functional priorities, then led Global Strategy and Operations for Allergan Aesthetics.
Dr. Donoghoe holds an M.D. from Johns Hopkins University and a B.S. from Duke University, and spent roughly a decade at McKinsey & Company serving global clients across oncology, immunology and neuroscience before joining AbbVie.